Xpert MTB/RIF-generated cycle-threshold (C T ) values have poor clinical utility as a rule-in test for smear positivity (cut-point #20.2; sensitivity 32.3%, specificity 97.1%) but moderately good rule-out value (cut-point .31.8; negative predictive value 80.0%). Thus, 20% of individuals with C T values .31.8 were erroneously ruled out as smear-negative. This group had a significantly lower sputum bacillary load relative to correctly classified smear-positive patients (C T # 31.8; P , .001). These data inform on public health and contact tracing strategies.
Individuals who test smear-positive for acid-fast bacilli are more likely to transmit tuberculosis [1, 2] . Xpert MTB/RIF (MTB/RIF; Cepheid) is a new molecular test endorsed by the World Health Organization (WHO) for the frontline diagnosis of tuberculosis [3, 4, 5] . Thus, MTB/RIF will be used to diagnose patients who have not undergone smear microscopy testing. Existing infection control and contact tracing guidelines rely on the smear status of patients to inform patient management [6, 7] . The diagnostic accuracy of MTB/RIF for predicting the smear status of individuals remains undescribed. Thus, it is unclear how patients who undergo only MTB/RIF testing should be managed. Furthermore, few tools are available to identify tuberculosis patients who are at risk of delayed sputum conversion and relapse due to a high baseline bacillary load [8, 9] . Further study of measures of bacterial burden, including smear status and grade, liquid culture time to positivity (TTP), and quantitative polymerase chain reaction cycle-threshold (C T ) values, are thus warranted. C T values are continuous variables inversely correlated with the concentration of starting material (in this case, the number of copies of the MTB complex rpoB gene) in the sputum.
METHODS
We recently evaluated MTB/RIF performance in a high human immunodeficiency virus (HIV) prevalence setting in Cape Town, South Africa [10, 11] . Here, we present the performance of C T values in 496 pretreatment patients with suspected tuberculosis, alone or in combination with other demographic and clinical factors, for the detection of smear-positive individuals and, of those who are smear-positive, those with the highest smear grade. This was evaluated using receiver operating characteristic (ROC) curve analysis, and cut-points were selected for their rule-in and rule-out values. In an attempt to improve predictive outcome, we performed a multivariable regression analysis using clinical and chest radiographic data (scored by at least 2 readers using the standardized chest radiograph scoring system [12] ). Furthermore, we performed an analysis of the relationship between C T values and the TTP of liquid cultures grown using the MGIT 960 system. Demographic details of the cohort and definitions of diagnostic categories are published elsewhere [10] .
RESULTS
Of the 496 patients with suspected tuberculosis, 141 had cultureconfirmed definite tuberculosis. One hundred and eleven of this definite tuberculosis group were MTB/RIF-positive, whereas an additional 19 patients were culture-negative and MTB/RIFpositive. We showed this latter group to likely represent true tuberculosis cases [10] . Of the 130 MTB/RIF-positive cases, 34 were smear-negative and 96 were smear-positive for acidfast bacilli ( (Table 1) .
At a cut-point of .31. In an attempt to improve predictive capability of the C T values, we derived a clinical prediction score (CPS) that incorporated demographic and clinical variables and the volume of sputum used for MTB/RIF testing ( Table 2 ; detailed CPS methodology in Supplementary data). The presence of selfreported weight loss (P 5 .05) and average C T values (P , .001) remained significant in the multivariate analysis (Table 2) and were weighted according to their b-coefficients in the final model for CPS derivation. In contrast to C T values, HIV status was not a significant predictor of smear status when included in the multivariate analysis; this is likely because C T values are a better proxy marker of bacterial load and have finer discriminative ability.
Use of the CPS resulted in a significant improvement in smear-positivity detection at a cut-point corresponding to use as a rule-in test (cut-point of #20.2; sensitivity of 49.5% vs 32.3% [P 5 .02]; Table 1 ). However, at the rule-out cut-point (#20.2), neither specificity (P 5 .28) or NPV significantly improved (P 5 .79). The area under the ROC curves for smear positivity or P111 detection also did not improve significantly (P 5 .16 and P 5 .33, respectively; Supplementary Figures 1 and 2) .
Finally, average C T values strongly correlated with liquid culture TTP (r s 5 0.56; P , .0001; linear regression formula: average C T 5 0.65 3 [TTP in days] 1 17.95). Thus, it is possible to equate MTB/RIF-generated C T values with liquid culture TTP.
DISCUSSION
MTB/RIF will now be performed instead of smear microscopy, given its endorsement by the WHO as a frontline technology for the diagnosis of tuberculosis [3, 4] . The key findings of our study were as follows: (1) MTB/RIF-generated average C T values have poor clinical utility as a rule-in test for smear positivity (sensitivity of 32.3% and specificity of 97.1% at a cut-point of #20.2), indicating that a positive result (ie, samples with C T values below the cut-point) could be interpreted with high confidence but when negative did not exclude the patient from being smear-positive (almost 70% of smear-positive individuals were erroneously classified as smear-negative); (2) MTB/RIF had a moderately high rule-out value for smear positivity (sensitivity of 95% and an NPV of 80.0% at a cut-point of .31.8), the clinical utility of which is detailed below; and (3) average C T values correlated well with TTP, a validated surrogate of mycobacterial burden and response to treatment [9] .
The moderately high NPV of MTB/RIF when used as a rule-out test for smear positivity is likely to be clinically useful, because above this cut-point of 31.8, 80% of smearnegative cases are correctly identified. Although 20% of individuals above this cut-point are smear-positive cases misclassified as smear-negative, these misclassified smear-positives are, of all the smear-positives, those with the lowest mycobacterial burden and may thus be less likely to transmit disease. From a contact tracing viewpoint, 95% of all smear-positive cases fall below this cut-point, but so do approximately 50% of all smear-negative cases. However, of all smear-negatives, this latter group has the highest burden of disease and hence likely the highest risk of disease transmission.
Thus, from a public health perspective, smear-positive cases with the least risk of transmission will be misclassified. However, Abbreviations: C T , cycle threshold; CI, confidence interval; PPV, positive predictive value; NPV, negative predictive value. a Defined as the best compromise between sensitivity and specificity assuming equal weighting (13) .
the precise relationship between MTB/RIF C T values and disease transmission remains to be determined and will require prospective molecular epidemiological transmission-based studies.
The poor rule-in value of MTB/RIF for both smear positivity and P111-graded individuals relates to the overlapping average C T values for each smear grade [10] . Thus, given this overlap, attainment of high specificity occurs at the expense of considerable sensitivity. TTP is a proxy marker of bacterial viability, whereas MTB/RIF and smear microscopy quantify both viable and nonviable organisms; however, we have shown a good correlation between TTP and average C T values and provided a method for equating these variables. Our data nonetheless have implications for clinical trials, which use longitudinal measurements of mycobacterial burden as surrogate markers of drug efficacy [8] .
There are several limitations of our study. The conclusiveness of our findings is limited by our small sample size and wide CIs, and thus can only be regarded as preliminary. The use of different spot sputum specimens from the same patient for smear microscopy and MTB/RIF might be a source of inaccuracy.
In summary our preliminary findings, which require confirmation in larger studies, indicate that MTB/RIF-generated average C T values of .31.8 provide moderately good rule-out value for smear positivity. Whether individuals falling above this cut-point, compared with those below, will display reduced disease transmission requires prospective validation. Our data have public health implications for the roll-out of MTB/RIF.
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